By now everybody knows the gist of the Theranos story: A high-flying blood testing startup led by a captivating CEO crashes to earth after revelations that its technology doesn’t work. The dogged reporting efforts by Wall Street Journal journalist John Carreyrou were instrumental in exposing a corporate fraud that many otherwise powerful and brainy people bought into.

Carreyrou’s new book about the Theranos saga, “Bad Blood,” offers a deeper look at what happened at the company and how it managed to achieve stunning sleights of hand. But as much as it’s a story about science and corporate intrigue, it’s also a tale about lawyers. And it doesn’t make Theranos’ long-serving counsel, David Boies and his firm, look all that great.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]